IRCT201602041556N86已完成未知
Simvastatin added to risperidone in the treatment of Autism: a double blind and placebo controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 4 years 至 12 years（—）
- 性别
- All
入选标准
- •DSM-5 clinical diagnosis of autistic disorder; children between the ages of 4 and 12 years old; presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone).
- •Exclusion criteria: presence of any active medical problem; any other psychiatric diagnosis except for mild mental retardation; receiving any psychotropic medications during past two weeks prior to the trial; presence of hepatic disease; history of seizure; history of allergy to simvastatin or intolerance of it; neutropenia, anemia or thrombocytopenia and renal disease.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosisPatients with decompensated cirrhosisMedDRA version: 20.0Level: LLTClassification code 10009209Term: Cirrhosis bilarySystem Organ Class: 100000004871EUCTR2018-001698-25-NLIDIBAPS240
进行中（未招募）
1 期
Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosisPatients with decompensated cirrhosisMedDRA version: 20.0Level: LLTClassification code 10009209Term: Cirrhosis bilarySystem Organ Class: 100000004871EUCTR2018-001698-25-GBIDIBAPS240
进行中（未招募）
1 期
Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosisPatients with decompensated cirrhosisMedDRA version: 20.0Level: LLTClassification code 10009209Term: Cirrhosis bilarySystem Organ Class: 100000004871EUCTR2018-001698-25-DEIDIBAPS240
进行中（未招募）
1 期
Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosisPatients with decompensated cirrhosisMedDRA version: 20.0Level: LLTClassification code 10009209Term: Cirrhosis bilarySystem Organ Class: 100000004871EUCTR2018-001698-25-ESIDIBAPS240
进行中（未招募）
1 期
Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosisAdult patients with decompensated cirrhosisMedDRA version: 20.0Level: LLTClassification code 10009209Term: Cirrhosis bilarySystem Organ Class: 100000004871EUCTR2018-001698-25-ITIDIBAPS (CONSORCIO INSTITUTO DE INVESTIGACIONES BIOMèDICAS AUGUST PI I SUNYER)240